Syneos Health, Inc. (NASDAQ:SYNH) is reporting third quarter earnings results on Thursday 29th October 2020, before market open.
The consensus estimates from Thomson Reuters are income of $ 0.91 per share.
For the full year, analysts predict revenues of $ 4517.83 million, while looking forward to income of $ 3.24 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 4,470.00 million ~ $ 4,570.00 million, where as bottomline are predicted in a range of $ 3.16 ~ $ 3.38 per share
Click Here For More Historical Outlooks Of Syneos Health, Inc.
Previous Quarter Performance
Syneos Health, Inc. recorded income for the second quarter of $ 0.58 per share, from the revenue of $ 1,013.00 million. The quarterly earnings fell 21.62 percent while revenues down 13.20 percent compared with the same quarter last year.
According to street consensus, SYNH was expected to report 2Q20 income of $ 0.48 per share from revenue of $ 990.78 million. The bottom line results beat street analysts by $ 0.1 or 20.83 percent, at the same time, top line results outshined analysts by $ 22.22 million or 2.24 percent.
Stock Performance
Shares of Syneos Health, Inc. traded low $ -2.55 or -4.56 percent on Wednesday, reaching $ 53.37 with volume of 713.70 thousand shares. Syneos Health, Inc. has traded high as $ 55.37 and has cracked $ 53.12 on the downward trend
According to the previous trading day, closing price of $ 53.37, representing a 86.28 % increase from the 52 week low of $ 30.02 and a 24.69 % decrease over the 52 week high of $ 74.25.
The company has a market capital of $ 5.55 billion and is part of the Healthcare sector and Diagnostics & Research industry.
Conference Call
Syneos Health, Inc. will be hosting a conference call at 8:00 AM eastern time on 29th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.syneoshealth.com
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions.
